Ka taƙaita labarin:  Wani sabon bincike ya nuna cewa mata na da hadarin kamuwa da cutar sankarar mama shekaru bayan sun daina shan maganin maye gurbin hormone. Masana kimiyya sun yi gargaɗi cewa maganin maye gurbin hormone yana ƙara haɗarin mace ta kamu da ciwon nono har shekara takwas bayan ta daina shan maganin. Sabbin binciken sun fito ne daga masana da suka gudanar da bincike mafi girma a duniya a kan tasirin HRT - da ake amfani da shi don rage tasirin menopause. Cibiyar Kula da Lafiya ta Mata a Amurka da Nazarin Mata Miliyan a Burtaniya duk sun bayyana tabbaci mai ƙarfi cewa HRT yana ƙara haɗarin mace na nono, mahaifa da kansar ovarian. Binciken Mata Miliyan, haɗin gwiwa tsakanin Cancer Research UK da NHS, sakamakon ya nuna cewa matan da ke amfani da haɗin HRT suna da haɗarin cutar sankarar mama sau biyu idan aka kwatanta da waɗanda ba masu amfani ba. Kuma masu bincike sun gano cewa idan mata sun yi amfani da HRT fiye da shekara 10, haɗarin su ya fi girma. Yanzu masana kimiyya da ke cikin binciken Women's Health Initiative sun yi gargaɗi, bayan ƙarin bincike, cewa matan da suke shan maganin HRT na haɗuwa da estrogen da progesterone suna ci gaba da samun haɗarin cutar sankarar mama, har zuwa shekaru takwas bayan sun daina maganin. Bayan ta wuce lokacin mazauni, ƙwaiyar mace ta daina samar da sinadarin estrogen. Yana haifar da bayyanar cututtukan menopausal ciki har da zafi da kuma yanayi. HRT tana bi da jiki ta hanyar gabatar da kwayoyin halittar mata. Akwai nau'i uku, HRT na estrogen kawai, HRT na cyclic - inda ake amfani da estrogen a kai a kai amma ana ba da progesterone ko dai kowane wata ko kowane watanni uku - da kuma ci gaba da hadewar HRT, inda ake amfani da kwayoyin halittar mata biyu a lokaci guda. A farkon shekarun 1990, wasu ƙananan karatu sun nuna cewa maganin zai rage haɗarin mace na cututtukan zuciya da osteoporosis. Don bincika ko haka ne, an ba da Hukumar Kula da Kiwon Lafiyar Mata a Amurka aikin bincike. Sun rubuta mata fiye da 26,000 masu shekaru 50 zuwa 79 a cikin binciken. A halin yanzu, a Burtaniya wani babban binciken, Million Women Study, ya binciki tasirin HRT akan mata...
HRT na kara hadarin kamuwa da cutar har zuwa shekaru takwas bayan dakatar da magani. Ya shafi wadanda ke shan hadewar HRT - estrogen da progesterone. Binciken da masana kimiyya suka yi daga daya daga cikin manyan binciken da aka yi a cikin HRT. Amma matan da ke shan maganin HRT na estrogen kawai na iya samun raguwar haɗari.